“
“The project absolutely met its aims and is gaining traction in the field where I already have reports that it has helped with interactions and positively increased sales”.
Pharma Value & Access Manager who commissioned an Mtech Access local payer communication tool
“
“[Mtech Access were] fantastic to work with [and] went over and above the standards expected”
Head of Market Access who commissioned a suite of UK HTA submissions
“
“I just want to say that the payer research project was really great. I understood it was a challenge but the team did an amazing job.”
HEOR LeadGlobal Market Access in a top 20 Pharma company
“
“The mock meeting was excellent and very well delivered. The team were so responsive, easy to communicate with, very flexible and able to implement things last minute. We would definitely do this again with Mtech!”
HTA & Access Lead Top 20 pharma company
“
“What Mtech Access do is unique. They have a set of people with varied and experienced roles who can translate between the NHS and industry and offer industry real-time feedback.”
Market Access ManagerTop 20 Pharma company
“
“I was really pleased with how the advisory board went. The outcomes were good and useful. If you are looking for something slightly different, go to Mtech. [When working with Mtech, ] we know we’re going to get what’s promised and that there will always be delegates with interesting roles who have a real desire to engage in the process.”
Market Access Manager, Top 20 pharma company Top 20 pharma company
“
“In my experience, the team at Mtech Access are among the best in the industry. It’s always a pleasure working with them as they are appreciative of their customers’ needs, ensure timely communication, and develop payer communication tools of utmost quality in line with my expectations.”
HEOR ManagerTop 20 Pharma company
“
“Today’s NHS Insights session was excellent. We really liked the content and format. Liz Cross, the NHS Advanced Nurse Practitioner who spoke, was really good value – very insightful – thanks for inviting her.”
Head of Market AccessPharma client
“
“Without Mtech Access we may have missed several deadlines, as we had multiple HTA submissions to coordinate and faced added disruption to timelines and processes due to the pandemic. The situation was challenging, and I don’t think we could have got through the process without the quality of the work, the complete understanding of the process, and fantastic project management delivered by Mtech Access.”
Head of Market Access, UK & IrelandPharma Company
“
“The HTA strategy and gap analysis from Mtech Access was highly satisfying and exceeded all expectations. We were impressed by how comprehensive the research was, and how dedicated the team were. The project management and communication from the team was perfect. 10/10.”
Senior Market Access and Public Affairs ManagerTop 20 Pharma Company
“
“It was great to get insights on the HTA landscape. The desk research done by Mtech Access was really detailed and identified a lot of gaps, whilst the experts that Mtech Access interviewed added a lot of value. The insights we gained have helped support our engagement with NICE and other stakeholders.”
Health Economics ManagerTop 20 Pharma Company
“
“Facing pressing resubmission deadlines, we reached out to Mtech Access to update our Systematic Literature Review and Data Analysis. I was very glad we did. We received the optimal outcome given the timelines – overall a very successful project!”
Global HEOR DirectorPharma Company
“
“Mtech Access is the best consultancy, in my opinion, due to the calibre of the people. The team were really easy to work with, were quick to action everything, and kept us updated on the whole process”
Senior Market Access and Reimbursement ManagerMedtech Company
